The University of Chicago Header Logo

Connection

Mark J. Ratain to CD56 Antigen

Back to Details
This is a "connection" page, showing publications Mark J. Ratain has written about CD56 Antigen.
Mark J. Ratain
Connection Strength
0.057
CD56 Antigen
  1. A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clin Cancer Res. 2002 Dec; 8(12):3718-27.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.